Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma.
AUTOR(ES)
Aronson, D L
RESUMO
We have investigated the pathway of prothrombin activation in blood and plasma. By means of a rapid purification procedure involving chromatography on DEAE-cellulose and hydroxyapatite, we demonstrated that the major prothrombin fragment in serum is that representing the amino-terminal half of prothrombin (i.e. F1-2). The F1-2 isolated was characterized by its size, amino acid and antigenic compositions, amino-terminal residue, and the peptides (designated F1 and F2, respectively) it yielded upon hydrolysis by thrombin. Measurements by the isotope dilution technique showed that F1-2 could account for the fate of at least 90% of the prothrombin originally present in plasma. By contrast, the serum concentration of the fragment representing the amino-terminal third of prothrombin (viz. F1) was less than 10% that of F1-2. These results demonstrated that the major route of prothrombin conversion in blood or plasma involves the removal of the combined activation fragment (F1-2) as a single peptide.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=372499Documentos Relacionados
- Thrombin generation and secretion of platelet Factor 4 during blood clotting.
- Relationship between Secretion of Platelet Factor 4 and Thrombin Generation during In Vitro Blood Clotting
- Evaluation of the marker of hypercoagulability prothrombin fragment F 1+2 in patients with mechanical or biological heart valve prostheses
- Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma.
- Antioxidant defenses and lipid peroxidation in human blood plasma.